WASHINGTON (Reuters) - U.S. authorities said on Thursday they told three companies to stop mass-producing and distributing unapproved medicines to treat asthma, bronchitis and other breathing disorders.
WASHINGTON (Reuters) - U.S. authorities said on Thursday they told three companies to stop mass-producing and distributing unapproved medicines to treat asthma, bronchitis and other breathing disorders.
